JPY 3455.0
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | 2.74 Billion | 1.22 Billion | 1.36 Billion | 1.04 Billion | 89.17 Million |
Net Income | 1.61 Billion | 2.09 Billion | 2.06 Billion | 1.38 Billion | 972.16 Million |
Depreciation & Amortization | 154.87 Million | 81.13 Million | 54.2 Million | 39.19 Million | 43.3 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 1.49 Billion | 67.93 Million | -323.24 Million | 92.77 Million | -858.51 Million |
Other non-cash items | -10.08 Million | -84.85 Million | 38.32 Million | -83.56 Million | 698.9 Million |
Investing Cash Flow | 688.87 Million | 69.19 Million | -752.7 Million | -598.27 Million | -27.81 Million |
Investments in PPE | -202.62 Million | -315.25 Million | -244.92 Million | -28.03 Million | -14.35 Million |
Acquisitions | -108.5 Million | - | - | -52.92 Million | - |
Investment purchases | -17.21 Million | -516.05 Million | -1.51 Billion | -517.55 Million | -513.95 Million |
Sales/Maturities of investments | 1.01 Billion | 900.51 Million | 1 Billion | 247 Thousand | 500.5 Million |
Other Investing Activities | -2000.00 | -3000.00 | -1000.00 | -1000.00 | -16 Million |
Financing Cash Flow | -843.42 Million | -910.67 Million | -751.91 Million | -520.08 Million | -520.01 Million |
Debt repayment | - | - | - | - | - |
Dividends payments | -494.49 Million | -511.61 Million | -433.28 Million | -519.94 Million | -519.95 Million |
Common Stock Repurchased | -348.92 Million | -399.05 Million | -334.27 Million | -131 Thousand | -62 Thousand |
Common Stock Issuance | - | - | 15.64 Million | - | - |
Other Financing Activities | -1 Million | -1000.00 | 15 Million | -1000.00 | -1 Million |
Accounts receivables | 61 Million | 241 Million | -953 Million | 847 Million | 287.68 Million |
Accounts payables | 1.41 Billion | -59.5 Million | 473.47 Million | -503.72 Million | -954.93 Million |
Inventory | 17.45 Million | -81.69 Million | 98.07 Million | -258.46 Million | -12.82 Million |
Other working capital | 66 Million | -42 Million | 123 Million | -51 Million | -178.44 Million |
Cash at beginning of period | 10.01 Billion | 9.6 Billion | 9.67 Billion | 9.74 Billion | 10.21 Billion |
Cash at end of period | 12.64 Billion | 10.01 Billion | 9.6 Billion | 9.67 Billion | 9.74 Billion |
Capital Expenditure | -202.62 Million | -315.25 Million | -244.92 Million | -28.03 Million | -14.35 Million |
Effect of forex changes on cash | 47.47 Million | 23.72 Million | 71.1 Million | 8.59 Million | -10 Million |
Net cash flow / Change in cash | 2.63 Billion | 411.87 Million | -72.6 Million | -69.42 Million | -469.25 Million |
Free Cash Flow | 2.54 Billion | 914.36 Million | 1.11 Billion | 1.01 Billion | 74.81 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 229 Million | 219 Million | 1.61 Billion | 318 Million | 298 Million | 239 Million |
Depreciation & Amortization | - | - | 154.87 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 1.49 Billion | - | - | - |
Other non-cash items | -229 Million | -219 Million | -10.08 Million | -318 Million | -298 Million | -239 Million |
Investing Cash Flow | - | - | 688.87 Million | - | - | - |
Investments in PPE | - | - | -202.62 Million | - | - | - |
Acquisitions | - | - | -108.5 Million | - | - | - |
Investment purchases | - | - | -17.21 Million | - | - | - |
Sales/Maturities of investments | - | - | 1.01 Billion | - | - | - |
Other Investing Activities | - | - | -2000.00 | - | - | - |
Financing Cash Flow | - | - | -843.42 Million | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | -494.49 Million | - | - | - |
Common Stock Repurchased | - | - | -348.92 Million | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -1 Million | - | - | - |
Accounts receivables | - | - | 61 Million | - | - | - |
Accounts payables | - | - | 1.41 Billion | - | - | - |
Inventory | - | - | 17.45 Million | - | - | - |
Other working capital | - | - | 66 Million | - | - | - |
Cash at beginning of period | - | - | 10.01 Billion | - | - | - |
Cash at end of period | - | - | 12.64 Billion | - | - | - |
Capital Expenditure | - | - | -202.62 Million | - | - | - |
Effect of forex changes on cash | - | - | 47.47 Million | - | - | - |
Net cash flow / Change in cash | - | - | 2.63 Billion | - | - | - |
Free Cash Flow | - | - | 2.54 Billion | - | - | - |
NSIT
EFG
AVA
NHIQ
KTWIF
AJANTPHARM